Literatur
Chuang YC, Chancellor MB (2006) The application of botulinum toxin in the prostate. J Urol 176: 2375–2382
El-Hakim A (2004) Chronic prostatitis/chronic pelvic pain syndrome: is there a role for local drug infiltration therapy? J Endourol 18: 227–231
Frenkl TL, Rackley RR (2005) Injectable neuromodulatory agents: botulinum toxin therapy. Urol Clin North Am 32: 89–99
Hampel C, Gillitzer R, Pahernik S et al. (2005) Drug therapy of female urinary incontinence. Urologe A 44: 244–255
Hochreiter WW, Z’Brun S (2004) Chronic pelvic pain syndrome and voiding dysfunction. Curr Urol Rep 5: 300–304
Khastgir J, Dickinson AJ (2003) Where do we stand with chronic prostatitis? An update. Hosp Med 64: 732–736
Krieger JN, Ross SO, Penson DF et al. (2002) Symptoms and inflammation in chronic prostatitis/chronic pelvic pain syndrome. Urology 60: 959–963
Litwin MS (2002) A review of the development and validation of the National Institutes of Health chronic prostatitis symptom index. Urology 60: 14–18
Litwin MS, McNaughton-Collins M, Fowler FJ Jr et al. (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 162: 369–375
Moormann O, Planz B, Caspers HP et al. (2004) Chronic prostatitis. Chronic pelvic pain syndrome. Schmerz 18: 125–129
Nickel JC, Nyberg LM, Hennenfent M (1999) Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 54: 229–233
Pontari MA (2003) Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment. Drugs Aging 20: 1111–1125
Pontari MA, Ruggieri MR (2004) Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 172: 839–845
Potts JM (2003) Chronic pelvic pain syndrome: a non-prostatocentric perspective. World J Urol 21: 54–56
Schaeffer AJ, Anderson RU, Krieger JN et al. (2006) The assessment and management of male pelvic pain syndrome including prostatitis. 6th International Consultation in Prostate Cancer and Prostate Disease. In: Mc Connel J, Abrams P, Denis L et al. (eds) Male lower urinary tract dysfunction. Evaluation and management. Health Publication, Paris, pp 343–385
Schneider H, Brähler E, Ludwig M et al. (2004) Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS. Urology 63: 1027–1030
Schneider H, Wilbrandt K, Ludwig M et al. (2005) Prostate-related pain in patients with chronic prostatitis/chronic pelvic pain syndrome. BJU Int 95: 238–243
Shin SM, Park DS (2006) Multiregional injections of low dose Botulinum Toxin A for men with chronic pelvic pain syndrome. J Urol A 175(Suppl): 104
Weidner W, Ludwig M, Brähler E et al. (1999) Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis. Drugs 58(Suppl 2): 103–110
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bschleipfer, T., Wagenlehner, F. & Weidner, W. Intraprostatische Botulinumtoxin-A-Injektion bei chronischer Prostatitis und chronischem Beckenschmerzsyndrom (CP/CPPS). Urologe 46, 1030–1032 (2007). https://doi.org/10.1007/s00120-007-1384-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-007-1384-8